WASATCH ADVISORS LP 13D/13G Filings for Ligand Pharmaceuticals Incorporated (LGND)

WASATCH ADVISORS LP 13D and 13G filings for Ligand Pharmaceuticals Incorporated:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-11
1:24 pm
Sale
2022-02-1113GLIGAND PHARMACEUTICALS INC
LGND
WASATCH ADVISORS LP312,901
1.200%
-1,561,001decrease
(-83.30%)
Filing